• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    18.39 Down 1.19(6.08%) Sep 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:19.58
    Open:19.61
    Bid:17.99 x 100
    Ask:22.50 x 500
    1y Target Est:24.11
    Beta:1.64854
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:18.19 - 19.70
    52wk Range:9.38 - 25.56
    Volume:978,559
    Avg Vol (3m):820,735
    Market Cap:1.27B
    P/E (ttm):N/A
    EPS (ttm):-1.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MNTADown 6.08%1.27B
    GSKDown 0.05%98.18B

    Key Statistics

    Forward P/E (1 yr):17.85
    P/S (ttm):15.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.22
    Quarterly EPS Est (Sep-15) :-0.03
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback